TABLE 3.
Samples | Zone of inhibition (mm) | ||
---|---|---|---|
P. aeruginosa | S. aureus | MRSA | |
Tp extract | 13.00 ± 0.82kl | 7.33 ± 0.47p | 8.00 ± 0.82op |
TpAgNP1 | 11.00 ± 0.82mn | 22.00 ± 0.82gh | 12.33 ± 0.47klm |
TpAgNP2 | 12.00 ± 00lm | 24.33 ± 1.70ef | 13.33 ± 0.47kl |
TpAgNP3 | 15.67 ± 0.94j | 23.67 ± 1.25fg | 13.00 ± 0.82kl |
TpAgNP4 | 20.33 ± 0.47h | 26.00 ± 0.82de | 12.67 ± 0.94klm |
TpAgNP5 | 17.33 ± 1.69ij | 22.00 ± 0.82gh | 12.00 ± 0.82lm |
TpAgNP6 | 28.33 ± 1.25c | 27.33 ± 0.47cd | 20.33 ± 0.47h |
TpAgNP7 | 16.00 ± 0.82ij | 25.33 ± 1.25ef | 17.67 ± 0.47i |
TpAgNP8 | 9.67 ± 1.25no | 20.33 ± 0.47h | 14.00 ± 0.82k |
TpAgNP9 | 8.33 ± 0.47op | 34.00 ± 0.82b | 16.67 ± 1.25ij |
DMSO | 0.00 ± 0.00q | 0.00 ± 0.00q | 0.00 ± 0.00q |
Ciprofloxacin | 36.00 ± 0.82a | 35.66 ± 0.47a | 20.66 ± 0.47h |
Tp, T. pallida; AgNP, silver nanoparticles; MRSA, methicillin-resistant S. aureus clinical isolate. Data represent mean ± standard deviation of triplicate.